Special Issue “Parkinson’s Disease: Genetics and Pathogenesis”
Open Access
Abstract
Parkinson’s disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65Keywords
Funding Information
- Fondation pour la Recherche Médicale (FRM, MND202004011718)
This publication has 16 references indexed in Scilit:
- Microarray Genotyping Identifies New Loci Associated with Dementia in Parkinson’s DiseaseGenes, 2021
- Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s DiseaseGenes, 2021
- Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s DiseaseGenes, 2021
- Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s DiseasePreprints.org, 2021
- Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread ImpactGenes, 2021
- Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s DiseaseGenes, 2021
- C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven HypothesisGenes, 2021
- GP2: The Global Parkinson's Genetics ProgramMovement Disorders, 2021
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesThe Lancet Neurology, 2019
- A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk lociNature Genetics, 2017